Technology
Health
Medical

Insulet

$150.24
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$1.17 (-0.77%) Today
$0.00 (0.00%) As of 4:00 PM EDT after-hours

Why Robinhood?

You can buy or sell Insulet and other stocks, options, ETFs, and crypto commission-free!

About PODD

Insulet Corporation Common Stock, also called Insulet, is a medical device company, which engages in the development, manufacture, and marketing of an insulin infusion system for people with insulin-dependent diabetes. It specializes in diabetes supplies, including the OmniPod System as well as other diabetes related products and supplies such as blood glucose testing supplies, traditional insulin pumps, pump supplies, and pharmaceuticals. Read More The company was founded by John L. Brooks III and John T. Garibotto in July 2000 and is headquartered in Acton, MA.

Employees
1,169
Headquarters
Acton, Massachusetts
Founded
2000
Market Cap
9.06B
Price-Earnings Ratio
529.95
Dividend Yield
0.00
Average Volume
922.57K
High Today
$153.95
Low Today
$147.78
Open Price
$152.86
Volume
536.87K
52 Week High
$155.52
52 Week Low
$70.80

Collections

Technology
Health
Medical
Advertising and Marketing
Business Services
US
North America
Female CEOs

PODD News

ReutersAug 15

Edited Transcript of PODD earnings conference call or presentation 8-May-17 8:30pm GMT

8

PODD Earnings

-$0.19
-$0.07
$0.04
$0.16
Q4 2017
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Estimated
$0.02 per share
Actual
$0.02 per share

More PODD News

All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.